The former Silicon Valley executive and convicted fraudster has officially kicked off an exploratory committee for her next startup, utilizing a high-profile true-crime documentary as an early-state stump speech.
In a bid to control the optics of her ongoing criminal liability, convicted fraudster Elizabeth Holmes has officially launched the exploratory phase of “Theranos 2.0” by allowing filmmakers Nathan Fielder and Lance Oppenheim to meticulously document her estrangement from reality.
Sources close to the Holmes camp described the media blitz as a calculated pivot toward radical transparency. Aides hope to preempt opposition research by providing the public with a pristine, multi-camera broadcast of the founder lying directly to a director’s face. The strategic rollout comes at a critical juncture for the former executive, who was actively drafting equity agreements for the new venture while packing her bags to begin an 11-year federal prison sentence for defrauding backers of her first one.
The campaign’s messaging strategy relies heavily on Holmes’s partner, Billy Evans, who has assumed the role of de facto communications director. Evans has maintained to the press pool that granting the filmmakers full access to their daily lives is the best way to market the couple’s new enterprise, effectively leveraging a documentary about the collapse of a multi-billion-dollar medical scam to court early-stage venture capitalists.
The rollout has not been without its debate-stage stumbles. During one particularly tense exchange leaked to the press, Fielder presses the candidate on whether she is presenting a manufactured persona. Holmes falls back on established talking points, assuring the comedian that she is "always being real" — a line that focus groups of former federal prosecutors have consistently flagged as deeply sociopathic.
Our internal numbers show that the venture capital base responds incredibly well to founders who double down on televised deception.
The coordinated media push is expected to conclude on the date of her self-surrender, at which point the Theranos 2.0 transition team will continue soliciting Series A funding from the visitation room at Federal Prison Camp Bryan.